Abstracts 1-8
1 Second hepatic resection for recurrent hepatocellular carcinoma
Sasan Roayaie, MD, Domenico Bassi, Spiros Hiotis, MD, Daniel Labow, MD, Myron Schwartz, MD, Mount Sinai Hospital, New York
2 Incorporating an HPB fellowship does not diminish surgical residents' HPB experience in a high-volume training program
Nicholas J Zyromski, MD, Laura Torbeck, PhD, David F Canal, MD, Keith D Lillemoe, MD, Henry A Pitt, MD, Indiana University, Indianapolis, IN.
3 Improved Survival with Aggressive Resection of Hilar CholangiocarcinomaYee Lee Cheah, MD, Mohamed Akoad, MD, Khashayar Vakili, MD, James J Pomposelli, MD, PhD, Elizabeth A Pomfret, MD, PhD, W David Lewis, MD,Roger L Jenkins, MD, Lahey Clinic, Burlington, MA.
4 Validation of a Predictive Algorithm to Maximize Resectability of Pancreatic Adenocarcinoma
Philip Bao, MD, Douglas Potter, PhD, Jennifer Young, David Eisenberg, MD, Diana Lenzner, MS, Kenneth Lee, MD, Herbert Zeh, MD, Michael Sanders,MD, Steven Hughes, MD, A. James Moser, MD, University of Pittsburgh, Pittsburgh, PA; UPCI Biostatistics Facility, Pittsburgh, PA.
5 Serial Molecular Analysis Of Eus Guided Fna Aspiration Of Pancreatic Cysts: Quantitative Molecular Evidence Detects Neoplastic CystProgression, Stability Or Regression Damien Mallat, MD, John P Tazelaar, Christine Spence, PhD, Elaine M Elder, ScD, Sydney D Finkelstein, MD, Baylor University, Dallas, TX; RedPathIntegrated Pathology, Pittsburgh, PA.
6 A Simple Risk Score Predicts Inpatient Mortality after Liver Resection for Hepatocellular Carcinoma
Jessica P Simons, MD, Sing Chau Ng, MS, Joshua S Hill, MD, Shimul A Shah, MD, Zheng Zhou, MD, PhD, Jennifer F Tseng, MD, MPH, University of Massachusetts Medical School, Worcester, MA.
7 SNPs IN RecQL Predict Survival In Pancreatic Adenocarcinoma
Marie-Claude Gingras, PhD, Donghui Li, PhD, Sally Elizabeth Hodges, Richard A Gibbs, PhD, F Charles Brunicardi, MD, William E Fisher, MD, Baylor, College of Medicine, Houston, TX; M. D. Anderson Cancer Center, Houston, TX.
8 Biliary Complications including a Single Donor Mortality: Experience of 207 Adult-to-Adult Living Donor Liver Transplantation.
Mahmoud A El-meteini, MD, Alaa F Hamza, MD, Amr A Abdalaal, MD, Mohamed F. Fathy, MD, Mohamed Bahaa, MD, Ahmed Mokhtar, MD, Fawzia Abouelfetouh, MD, Ibrahim Mostafa, MD, Ahmed El-dorry, MD, Ain-Shams University, Cairo, Egypt; Wady ElNeel Hospital, Cairo, Egypt
|